The article reports that the development of an impressive nine-enzyme biocatalytic cascade for the synthesis of the investigational drug islatravir for the treatment of human immunodeficiency virus (HIV). Topics discussed include potential application of biocatalysis to revolutionize industrial chemical processes; collaborating to develop biocatalysts for the synthesis of important pharmaceuticals; and important features that sets biocatalysts apart from the traditional chemical catalysts.
Processing Request
No Comments.